v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
 3 Months Ended
Dec. 30, 2022
Accounting Policies [Abstract]  
Schedule of Cash and Cash Equivalents Cash and cash equivalents and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows consisted of the following:
Three Months EndedThree Months Ended
December 30, 2022December 31, 2021
(In millions)Beginning of PeriodEnd of PeriodBeginning of PeriodEnd of Period
Cash and cash equivalents$89.4 $81.5 $144.6 $157.8 
Restricted cash1.2 1.3 1.5 1.4 
Total as presented in the Condensed Consolidated Statements of Cash Flows$90.6 $82.8 $146.1 $159.2 
Restrictions on Cash and Cash Equivalents Cash and cash equivalents and restricted cash as reported within the Condensed Consolidated Statements of Cash Flows consisted of the following:
Three Months EndedThree Months Ended
December 30, 2022December 31, 2021
(In millions)Beginning of PeriodEnd of PeriodBeginning of PeriodEnd of Period
Cash and cash equivalents$89.4 $81.5 $144.6 $157.8 
Restricted cash1.2 1.3 1.5 1.4 
Total as presented in the Condensed Consolidated Statements of Cash Flows$90.6 $82.8 $146.1 $159.2 
Summary of Customers with a Significant Portion of Revenue During the periods presented, one of the Company's customers accounted for a significant portion of revenues, as set forth below:
Three Months Ended
December 30, 2022December 31, 2021
Canon Medical Systems Corporation20.1 %19.2 %
Schedule of Product Warranty Liability The following table reflects the changes in the Company’s accrued product warranty:
Three Months Ended
(In millions)December 30, 2022December 31, 2021
Accrued product warranty, at beginning of period$7.9 $8.5 
New accruals charged to cost of revenues2.8 1.2 
Product warranty expenditures(3.0)(2.5)
Accrued product warranty, at end of period$7.7 $7.2